Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
Nature Communications
|
November 20, 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, et al.
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
Cancer Cell
|
February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Jenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
Cell
|
October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancer
Natalie Jäger, Matthias Schlesner, David T W Jones, et al.
Cancers
|
April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
Laura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Nature Genetics
|
June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen, Jan Koster, Linda J Valentijn, et al.
Nature Communications
|
June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
Ravi S Narayan, Piet Molenaar, Jian Teng, et al.
Oncotarget
|
August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
Johannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Cell
|
May 11, 2015
Prospective derivation of a living organoid biobank of colorectal cancer patients
Marc van de Wetering, Hayley E Francies, Joshua M Francis, et al.
Nature
|
May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Volker Hovestadt, David T W Jones, Simone Picelli, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
Nature Communications
|
November 20, 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, et al.
Journal of the National Cancer Institute
|
March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
Cancer Cell
|
February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Jenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
Cell
|
October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancer
Natalie Jäger, Matthias Schlesner, David T W Jones, et al.
Cancers
|
April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
Laura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Nature Genetics
|
June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen, Jan Koster, Linda J Valentijn, et al.
Nature Communications
|
June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
Ravi S Narayan, Piet Molenaar, Jian Teng, et al.
Oncotarget
|
August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
Johannes Fabian, Desirée Opitz, Kristina Althoff, et al.
Cell
|
May 11, 2015
Prospective derivation of a living organoid biobank of colorectal cancer patients
Marc van de Wetering, Hayley E Francies, Joshua M Francis, et al.
Nature
|
May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Volker Hovestadt, David T W Jones, Simone Picelli, et al.
Page
of 14